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Abstract
Purpose Higher long-chain polyunsaturated fatty acids
(LCP) in infant compared with maternal lipids at delivery
is named biomagnification. The decline of infant and
maternal docosahexaenoic acid (DHA) status during lac-
tation in Western countries suggests maternal depletion.
We investigated whether biomagnification persists at life-
long high fish intakes and whether the latter prevents a
postpartum decline of infant and/or maternal DHA status.
Methods We studied 3 Tanzanian tribes with low (Maasai:
0/week), intermediate (Pare: 2–3/week), and high (Senger-
ema: 4–5/week) fish intakes. DHA and arachidonic acid
(AA) were determined in maternal (m) and infant (i) eryth-
rocytes (RBC) during pregnancy (1st trimester n = 14,
2nd = 103, 3rd = 88), and in mother–infant pairs at deliv-
ery (n = 63) and at 3 months postpartum (n = 104).
Results At delivery, infants of all tribes had similar
iRBC-AA which was higher than, and unrelated to, mRBC-
AA. Transplacental DHA biomagnification occurred up to
5.6 g% mRBC-DHA; higher mRBC-DHA was associated
with ‘‘bioattenuation’’ (i.e., iRBC-DHA \ mRBC-DHA).
Compared to delivery, mRBC-AA after 3 months was
higher, while iRBC-AA was lower. mRBC-DHA after
3 months was lower, while iRBC-DHA was lower (low fish
intake), equal (intermediate fish intake), and higher (high
fish intake) compared to delivery. We estimated that
postpartum iRBC-DHA equilibrium is reached at 5.9 g%,
which corresponds to a mRBC-DHA of 6.1 g% throughout
pregnancy.
Conclusion Uniform high iRBC-AA at delivery might
indicate the importance of intrauterine infant AA status.
Biomagnification reflects low maternal DHA status, and
bioattenuation may prevent intrauterine competition of
DHA with AA. A mRBC-DHA of about 6 g% during
pregnancy predicts maternal–fetal equilibrium at delivery,
postnatal iRBC-DHA equilibrium, but is unable to prevent
a postnatal mRBC-DHA decline.
Keywords Biomagnification  Bioattenuation 
Pregnancy  Long-chain polyunsaturated fatty acids 
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Introduction
The long-chain polyunsaturated fatty acids (LC-PUFA)
docosahexaenoic (DHA), eicosapentaenoic (EPA), and
arachidonic (AA) acids are structural components of
membrane phospholipids [1]. DHA and AA are notably
abundant in the central nervous system and play important
roles in fetal and infant neurodevelopment [2]. DHA, EPA,
and AA are derived either from the diet or from endoge-
nous synthesis from their respective parent essential fatty
acids (EFA), linoleic (LA), and alpha-linolenic (ALA)
acids. Fatty fish are rich sources of EPA and DHA. Dietary
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sources of preformed AA are meat, eggs, and poultry [3],
while lean and tropical fish are rich sources of AA [4]. It is
suggested that LC-PUFA intakes from our Paleolithic diet
have been much higher [5–7] than presently observed in
the majority of affluent countries [8, 9]. The high AA and
DHA contents of our Paleolithic diet may imply that
human evolution, and thus also intrauterine development,
took place at high maternal intakes of both AA and DHA
[5].
Pregnant and lactating women have high LC-PUFA
needs [10]. This is notably the case for DHA that becomes
synthesized from ALA with difficulty [11]. Both AA and
DHA are important during infant development. More AA
than DHA accretes in brain in the early intrauterine period,
while DHA accretes rapidly from week 30 of pregnancy to
2 years postpartum [12]. The commonly observed higher
LC-PUFA in circulating cord plasma lipids as compared to
maternal plasma lipids has been coined ‘‘biomagnification’’
[13]. The declines of infant DHA status during lactation
and of the maternal DHA status during pregnancy [14] and
lactation [15] reflect the low LCPx3 status in many Wes-
tern countries.
The outcomes of randomized controlled trials aiming at
the improvement of neurodevelopment by the supplemen-
tation of pregnant women or their infants with fish oil,
DHA [16–18], or DHA ? AA [19] indicate subtle positive
effects at most. This contrasts with the positive relation-
ships between neonatal brain DHA and cognitive and
behavioral performance that are noted in the combined
human and animal studies [20–22]. Failure to show
favorable effects of LC-PUFA might, among many other
reasons, relate to the use of too low dosages and the study
of Western populations with low fish intakes without
stratification based on baseline DHA status [23].
There is substantial evidence that land–water ecosys-
tems have been exploited by our early African ancestors [5,
24, 25], and it is also known that some rural African
populations have much higher milk LC-PUFA contents [4,
26] as compared to those living in Western countries. Data
on the concurrent maternal and infant LC-PUFA status
during pregnancy and lactation in these African popula-
tions, however, are currently lacking. In view of this lack
of data, we determined the maternal and infant DHA and
AA status in 3 traditional rural African populations with
different levels of fish intakes. Since a longitudinal study
design proved impossible in these populations, we col-
lected data deriving from different women during preg-
nancy, at delivery and at 3 months postpartum. The
selected populations live in Tanzania and have low (Maa-
sai), intermediate (Pare), or high (Sengerema) intakes of
freshwater fish. All 3 populations are characterized by the
consumption of diets that are constrained in their varieties
by the availability of the food in their immediate
environment. Red blood cell (RBC) LC-PUFA contents
served as proxies for LC-PUFA status [27]. We were
particularly interested to see whether ‘‘biomagnification’’
and maternal DHA losses during pregnancy and lactation
also occur at lifetime high intakes of fish and at what
maternal LC-PUFA status the infant reaches a state of
postnatal LC-PUFA equilibrium.
Subjects and methods
Subjects, diet, and cultural circumstances
We selected 3 Tanzanian ethnic tribes with different
intakes of local freshwater fish, i.e., the Maasai (no or low
fish intake, 0/week), subjects from the Pare Mountains
(intermediate fish intake, 2–3/weeks), and subjects from
Sengerema (high fish intake, 4–5/weeks). We [4] have
previously shown that East African freshwater fish contain
high proportions of both DHA and AA and relatively low
EPA as compared to European saltwater fish. We experi-
enced that collection of longitudinal data was virtually
impossible. Patients’ appointments in the hospital were not
scheduled nor were we able to motivate subjects to par-
ticipate in a longitudinal study.
The selected Maasai were Nilotic pastoralists who live
in ‘‘bomas’’ (villages) in the Maasai Steppe nearby Ruvu.
Their diet consists mainly of curdled milk and meat. It has
recently become replenished with some ugali (corn por-
ridge). Consumption of fish is uncommon, since it is con-
sidered inedible. The Pare group was composed of women
of the Bantu tribes Pare and Sambaa from the Pare
Mountains. Their diet was mainly composed of vegetables,
beans, and fruits with ample ugali, rice and chapati
(cornwheat pancakes), and some meat or fish. The third
population was composed of women from Sengerema
(southern shore of Lake Victoria). Apart from the abundant
consumption of fish, they also consume ugali, muhogo
(cassava root), and plantain (baked banana).
The ethnicity/tribe of each of the study groups was
considered to be homogeneous. Most women were of low
socioeconomical background. Their incomes were derived
from pastoralism (Maasai), agriculture (Pare), or fisheries
(Sengerema). The studied populations neither had possi-
bilities nor interest in changing their cultural habits,
including their diets. Local hospital staff members and
interviews with the participants confirmed that neither
pregnancy nor lactation is associated with any change in
dietary habits or the prohibition of certain foods (F. Peters,
R. S. Kuipers, F. A. J. Muskiet, unpublished data). Their
dietary compositions were therefore likely to be represen-
tative for the lifetime dietary habits of each of the ethnical
groups.
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Women were included if they were apparently healthy
and well nourished and had delivered an apparently healthy
child at term (37–42 weeks, by estimate). Use of tobacco
and alcohol is almost nonexistent in these populations,
especially among women. Anthropometric data and a
questionnaire on fish intake were obtained from the med-
ical records or by interviews in Kiswahili. Besides the
measurement of fundal heights, reliable data on gestational
age were not always available, since some women had no
recollection of their last menstrual period. Devices for echo
imaging were either not available or not operational. All
women gave their informed consent. The study was
approved by the National Institute for Medical Research in
Dar-es-Salaam (NIMR/HQIR.8a/Vol. IX/145, dated June
16, 2003 and NIMR/HQ/R.8a/Vol. IX/800, dated April 8,
2009) and was in agreement with the Declaration of Hel-
sinki 1975 as revised in 2000.
Samples and analyses
We collected about 4 mL EDTA-anticoagulated venous
blood of the mothers during pregnancy and at delivery and
about 4 mL EDTA-cord blood at delivery (BD Vacutainer,
Plymouth, UK). At 3 months postpartum, about 4 mL
EDTA-anticoagulated venous blood of the mothers was
collected. About 250 lL EDTA-anticoagulated blood
(250 lL pediatric MiniCollect K3EDTA-tubes; Greiner
Bio-one, Kremsmu¨nster, Austria) was taken by heel prick
from the 3-months-old infants. The samples were stored at
4 C in the dark and processed within 2 h after collection.
RBC were isolated by centrifugation and washed three
times with 0.9% NaCl. After washing, 200 lL of the RBC
suspension (mothers) or the entire RBC suspension
(infants) was transferred to a Teflon-sealable Sovirel tube
containing 2 mL of methanol-6 mol/L HCl (5:1 v/v), 1 mg
butylated hydroxytoluene (antioxidant), and 50 lg 17:0.
All samples were transported at ambient temperature to the
University Medical Center Groningen (The Netherlands)
for fatty acid analysis. Within 9 months after collection,
the methanol–HCl conserved samples were transmethylat-
ed by heating at 90 C for 4 h. Subsequent analysis of fatty
acid methyl esters was performed, by capillary gas chro-
matography/flame ionization detection according to previ-
ously described procedures [28]. Fatty acid compositions
were expressed in g% (g/100g).
Statistics
Statistical analyses were performed with SPSS version 16.0
(SPSS Inc, Chicago, IL). Within-tribe differences of
mothers and infants at delivery were compared with cor-
responding data at 3 months postpartum by use of the
Mann–Whitney U test. Mother–infant pair differences were
tested with a Wilcoxon two-related samples test. In both
instances, p \ 0.05 was considered significant. Between-
group differences were studied with the aid of the Kruskal–
Wallis test, followed by the analyses with Mann–Whitney
U test (nonparametric) at p \ 0.05. Corrections were made
for type-1 errors (Bonferroni correction). Equations were
derived from linear regression analysis. We used the
coefficient of determination (R2) to estimate the extent to




We included 205 different pregnant women. Of these, 14
women were included in their 1st trimester of pregnancy
(defined as 1–13 weeks; 3 Maasai, 4 Pare, and 7 Senger-
ema), 103 women in the 2nd trimester (14–27 weeks; 14
Maasai, 47 Pare, and 42 Sengerema), and 88 women in the
3rd trimester (28 weeks delivery; 16 Maasai, 41 Pare, and
31 Sengerema). Table 1 shows the characteristics of all
pregnant women. There were no between-trimester differ-
ences in the general characteristics for each of the tribes.
From the data of different trimesters, only body weight is
shown. The Pare (p \ 0.005) and Sengerema (p \ 0.001)
women in the 2nd and 3rd trimesters were heavier than the
Maasai women and had a higher BMI during pregnancy
compared to the Maasai (p \ 0.001). The number of pre-
vious pregnancies was lower in Pare women, compared
with Maasai (p = 0.003) and Sengerema (p = 0.003)
women. The, for the current study, most relevant between-
tribe difference was in fish intake. Fish consumption
increased in the order Sengerema [ Pare [ Maasai.
Mother–infant pairs at delivery and at 3 months
postpartum
We included 73 mother–infant pairs at delivery (8 Maasai, 31
Pare, and 34 Sengerema) and 110 different mother–infant
pairs (9 Maasai, 40 Pare, and 61 Sengerema) after 3 months
of exclusive breastfeeding. Their characteristics are also
shown in Table 1. There were no between-tribe differences
for the mothers at delivery or at 3 months postpartum, except
for a lower BMI at delivery (p = 0.001) and higher length
(p = 0.015) of the Maasai mothers compared to Pare
mothers. Also in these groups, fish consumption occurred in
the order Sengerema [ Pare [ Maasai at delivery and at
3 months postpartum.
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Erythrocyte AA and DHA
RBC-FA data were available from all 205 women during
pregnancy. At delivery, we studied different subjects.
RBCs were available of 6 Maasai, 27 Pare, and 34 Sen-
gerema women and 8 Maasai, 29 Pare, and 36 Sengerema
infants. At 3 months postpartum, we included a group of
different subjects including 9 Maasai, 38 Pare, and 60
Sengerema women and 8 Maasai, 38 Pare, and 61 Sen-
gerema infants. Drop-out was due to failure to obtain
consent for both mother and infant, early discharge (only at
delivery), and logistical and analytical imperfections
(delivery and 3 months postpartum).
Between- and within-tribe RBC-AA differences
and mother–infant RBC-AA relation
Figure 1a (left panel) shows the apparent maternal and
infant RBC-AA courses from the first trimester to 3 months
postpartum. For convenience, data points are connected
with dotted lines, but it should be noted that they are
derived from different study groups. Visual inspection of
the apparent courses of maternal RBC-AA during preg-
nancy did not reveal consistent changes. Maternal RBC-
AA seemed to decrease in Pare (intermediate fish), but
appeared constant in Maasai (low fish) and Sengerema
(high fish) mothers. We analyzed between-tribe maternal
RBC-AA differences at delivery. RBC-AA of Maasai
women was higher than RBC-AA of Pare (p = 0.005) and
Sengerema (p \ 0.001), whereas Pare and Sengerema
women did not show differences. The RBC-AA of the
infants showed no between-tribe differences at delivery.
Within-tribe analysis of RBC-AA showed that in Maa-
sai, Pare, and Sengerema mothers, RBC-AA at delivery
was lower than at 3 months postpartum (p B 0.001). In
Maasai infants, there were no differences in RBC-AA
between delivery and 3 months postpartum, whereas in
Pare and Sengerema infants, RBC-AA was significantly
Table 1 Characteristics of
pregnant women and mother–
infant couples at delivery and at
3 months PP
Values are mean ± SD (n).
Different superscripts indicate
significant different means,
p \ 0.017; PP, postpartum
Maasai Pare Sengerema
Pregnant women
Maternal age, y 25 ± 8 (33) 26 ± 6 (92) 26 ± 6 (80)
Weight, kg trimester 1 50.7 ± 6.4 (3) 54.8 ± 16.5 (4) 54.9 ± 8.2 (7)
Weight, kg trimester 2 52.1 ± 4.4 (14)a 56.8 ± 8.2 (47)b 58.6 ± 7.0 (42)b
Weight, kg trimester 3 52.9 ± 4.7 (16)a 59.3 ± 8.9 (41)b 61.5 ± 3.9 (31)b
Height, m 1.60 ± 0.06 (33) 1.57 ± 0.10 (92) 1.59 ± 0.06 (80)
BMI, kg/m2 20.8 ± 1.4 (33)a 23.6 ± 3.2 (92)b 23.6 ± 2.7 (80)b
Gravida, n 4 ± 3 (32)b 3 ± 1 (92)a 4 ± 2 (80)b
Para, n 3 ± 3 (32)b 1 ± 1 (92)a 3 ± 2 (79)b
Fish intake, times/week 0 ± 0 (33)a 2 ± 1 (92)b 4 ± 2 (70)c
Delivery
Maternal age, y 23 ± 4 (8) 25 ± 7 (31) 24 ± 7 (34)
PP weight, kg 53.0 ± 5.0 (8) 57.3 ± 7.6 (23) 54.4 ± 10.2 (31)
Height, m 1.59 ± 0.06 (8)a 1.54 ± 0.04 (27)b 1.56 ± 0.06 (31)a,b
BMI, kg/m2 20.9 ± 2.0 (8)b 23.9 ± 2.0 (21)a 22.4 ± 3.3 (31)b
Gravida, n 3 ± 1 (8) 3 ± 2 (31) 3 ± 3 (34)
Para, n 2 ± 1 (8) 2 ± 2 (31) 2 ± 3 (34)
Gestational age at birth, week 40.0 ± 0 (1) 39.9 ± 1.5 (17) 38.9 ± 1.8 (28)
Fish intake, times/week 0 ± 0 (8)a 3 ± 2 (17)b 5 ± 2 (30)c
Infant birth weight, g 3,050 ± 400 (8) 3,115 ± 535 (26) 2,947 ± 751 (34)
Gender, % male 38 (8) 45 (29) 58 (36)
3 months PP
Maternal age, y 24 ± 4 (9) 24 ± 4 (40) 24 ± 6 (61)
PP weight, kg 52.4 ± 3.0 (9) 52.2 ± 10.9 (40) 54.6 ± 9.8 (61)
Height, m 1.60 ± 0.03 (9) 1.55 ± 0.07 (40) 1.56 ± 0.06 (61)
BMI, kg/m2 20.5 ± 1.1 (9) 21.6 ± 4.0 (40) 22.1 ± 3.0 (61)
Para, n 3 ± 1 (9) 2 ± 1 (40) 3 ± 2(61)
Fish intake, times/week 0 ± 1 (8)a 3 ± 2 (40)b 4 ± 2 (61)c
Infant age, week 16 ± 4 (9) 14 ± 3 (40) 13 ± 2 (61)
Gender, % male 67 (9) 47 (40) 55 (61)
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higher at delivery as compared to 3 months postpartum
(p B 0.001). In all tribes, we found that at delivery, infant
RBC-AA was significantly higher compared to maternal
RBC-AA (Maasai p = 0.028, Pare p \ 0.001, and Sen-
gerema p \ 0.001), but there was no relationship between
infant RBC-AA and maternal RBC-AA (Fig. 2a).
Taken together, maternal RBC-AA was consistently
lower at delivery compared to 3 months postpartum.
Infant RBC-AA contents were similar at delivery and
consistently higher than maternal RBC-AA. Thus, bio-
magnification of AA during pregnancy occurred, irre-
spective of maternal AA status (Figs. 1a, 2a). After
3 months of exclusive breastfeeding, infant RBC-AA was
lower compared to delivery in Pare (intermediate fish) and
Sengerema (high fish). This decline did not reach signif-
icance for the Maasai (low fish), probably because of low
numbers.
Between- and within-tribe RBC-DHA differences
and mother–infant RBC-DHA relation
Figure 1b (right panel) shows the apparent courses of
maternal and infant RBC-DHA contents from the first tri-
mester to 3 months postpartum. Visual inspection of
maternal RBC-DHA during pregnancy revealed a trend of
higher RBC-DHA in late pregnancy of the Pare and the
Maasai, but not the women in Sengerema. Analysis of the
between-tribe maternal and infant RBC-DHA differences
showed that at delivery, RBC-DHA in Sengerema (high
fish) women was higher compared to Pare (intermediate
fish) and Maasai (low fish) at p B 0.001, whereas Pare and
Maasai women showed no differences.
Within-tribe RBC-DHA differences showed that in all
tribes, maternal DHA at delivery was higher than at
3 months postpartum (Maasai p = 0.003; Pare and Sen-
gerema p B 0.001). In the infants, Maasai had higher RBC-
DHA at delivery compared to 3 months postpartum
(p = 0.039); Pare did not show a significant difference
between delivery and 3 months postpartum, while Sen-
gerema infants showed a lower RBC-DHA at delivery
compared to 3 months postpartum (p = 0.027).
At delivery, the analysis of mother–infant pairs differ-
ences revealed that Maasai (low fish) (p = 0.245) and Pare
(intermediate fish) (p = 0.091) infants, although insignifi-
cant, tended to have higher RBC-DHA than their mothers,
while (in contrast) the RBC-DHA of the Sengerema (high
fish) infants was lower (p = 0.029) compared to their
mothers. The relationship between maternal and infant
RBC-DHA at delivery is shown in Fig. 2b. For this anal-
ysis, we selected data of complete mother–infant pairs (6
Maasai, 24 Pare, and 33 Sengerema). At low maternal
DHA status, infants usually had higher RBC-DHA than
their mothers (biomagnification), but in contrast, at high
maternal DHA status, infant RBC-DHA was generally
lower (‘‘bioattenuation’’). Figure 2b indicates that equal
RBC-DHA in mothers and infants at delivery was reached
at a maternal RBC-DHA of 5.6 g%.
Although our data are not longitudinal, it appeared that at
low maternal RBC-DHA, infant RBC-DHA decreased from
delivery until 3 months postpartum, whereas at high mater-
nal DHA status, infant RBC-DHA increased from delivery
until 3 months postpartum. We subsequently calculated the
maternal DHA status at which the infant appeared to be in a
state of postpartum DHA equilibrium. In other words, we
Mother, infant Maasai, low
Mother, infant Pare, intermediate







































1st 2nd 3rd delivery 3 mo PP
Trimester of pregnancyTrimester of pregnancy
Mother, infant Maasai, low
Mother, infant Pare, intermediate
Mother, infant Sengerema, high
Fig. 1 Apparent courses of red blood cell (RBC) arachidonic acid
(AA, panel A) and docosahexaenoic acid (DHA, panel B) from the
first trimester of pregnancy up to 3 months postpartum for Maasai
(low fish), Pare (intermediate fish), and Sengerema (high fish) women
and infants. Data represent means ± 2SEM in g/100 g (g%) fatty
acids. They are derived from different maternal subgroups at the 1st,
2nd, and 3rd trimester and different mother–infant pairs at delivery
and 3 months postpartum. Maternal and infant data are represented by
closed and open symbols, respectively. PP, postpartum ? signifi-
cantly (sign) different from Maasai, pilcrow sign different from Pare,
yen sign different from Sengerema, closed circle sign different from
delivery, infinity sign different from mother
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estimated the maternal RBC-DHA status from which the
infant showed no changes in RBC-DHA from delivery to
3 months postpartum. Figure 3 shows the relationship
between infant RBC-DHA at delivery and at 3 months
postpartum for the Maasai, Pare, and Sengerema. Only mean
values for each of the tribes could be used, since we did not
study the same infants at delivery and at 3 months post-
partum. Figure 3 indicates that a postpartum infant RBC-
DHA equilibrium was reached at an infant RBC-DHA of
5.9 g% at delivery. In turn, this infant RBC-DHA corre-
sponds with a maternal RBC-DHA of 6.1 g% at delivery (by
inserting 5.9 into equation of Fig. 2b). The number of
included Maasai was low. Exclusion of their data did, how-
ever, not change the equation in Fig. 3.
Taken together, maternal RBC-DHA contents at both
high and low DHA status were lower after 3 months of
exclusive lactation, compared with delivery. Biomagnifi-
cation of DHA seems to occur up to a maternal RBC-DHA
of 5.6 g% at delivery, and from this turning point, DHA
becomes ‘‘bioattenuated.’’ Postpartum infant RBC-DHA
equilibrium was reached at an infant RBC-DHA of about
5.9 g% at delivery, corresponding to a maternal RBC-DHA
of 6.1 g% during pregnancy and at delivery. For all prac-
tical reasons, we conclude that biomagnification takes
place up to a maternal RBC-DHA status of about 6 g%,
and that also infant postnatal RBC-DHA equilibrium is
reached at about 6 g%.
Discussion
We determined the RBC-AA and DHA contents of preg-
nant Tanzanian women and of mother–infant pairs at
delivery and at 3 months postpartum. The mothers had
stable dietary intakes characterized by low (Maasai),
intermediate (Pare), and high (Sengerema) consumption of
freshwater fish. Our main findings are that biomagnifica-
tion of AA occurs irrespective of maternal AA status. In
contrast to maternal RBC-AA, infant RBC-AA at delivery
was remarkably uniform and also after 3 months exclusive
lactation, although to a lesser extent. There was no rela-
tionship between maternal and infant RBC-AA. From
delivery to 3 months postpartum, maternal RBC-AA
A
y = x at  5.6 g% RBC-DHA
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Fig. 2 Relationships between maternal and infant red blood cell
(RBC) contents of AA (panel A) and DHA (panel B) at delivery for
Maasai (low fish) (n = 6), Pare (intermediate fish) (n = 24), and the
Sengerema (high fish) (n = 33) women and infants. Dotted lines
indicate y = x for ‘‘equal AA or DHA sharing.’’ Maternal versus
infant RBC-AA at delivery is insignificant. At delivery, maternal
RBC-DHA equals infant RBC-DHA at 5.6 g%
Maasai, low          
Pare, intermediate
Sengerema, high
2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0
























x = y at 5.9 g% DHA
y = 1.37x –2.17, R 2 = 0.99 p = 0.034
Fig. 3 Relationship between the mean red blood cell (RBC) doco-
sahexaenoic acid (DHA) at delivery and at 3 months postpartum for
the Maasai, Pare, and Sengerema infants, respectively. Data represent
means ± 2SEM in g/100 g (g%) fatty acids. Infant RBC-DHA at
delivery equals infant RBC-DHA at 3 months postpartum at 5.9 g%
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increased, while infant RBC-AA decreased. Maternal and
infant RBC-DHA were higher in the sequence Sengerema
(high fish) [ Pare (intermediate fish) [ Maasai (low fish).
In contrast to RBC-AA, maternal and infant RBC-DHA
were intimately related. Biomagnification of DHA occur-
red up to a maternal RBC-DHA of 5.6 g% at delivery; from
this turning point, DHA became ‘‘bioattenuated’’. From
delivery to 3 months postpartum, maternal RBC-DHA
decreased, while infant RBC-DHA decreased in Maasai
(low fish), remained constant in Pare (intermediate fish),
and increased in Sengerema (high fish). Postpartum infant
RBC-DHA equilibrium was reached at an infant RBC-
DHA of about 5.9 g% at delivery, corresponding to a
maternal RBC-DHA of 6.1 g% during pregnancy and at
delivery.
Arachidonic acid (AA)
The higher RBC-AA contents in Maasai (low fish), com-
pared to Pare (intermediate fish) and Sengerema (high fish)
mothers (Fig. 1a), are likely to be caused by their higher
intakes of AA from meat and their low intakes of DHA
from fish. Biomagnification [13] of AA is consistent with
data from many others studying plasma PL [14, 29] or RBC
[30–32]. Higher infant compared to maternal RBC-AA at
delivery was previously found by us in Dominica [33] and
by others in the Netherlands [32], and the data of those 2
studies fitted well within those of the present study
(Dominica: mean maternal RBC-AA 12.4 g%, infant
16.6 g%; Netherlands: mean maternal RBC-AA 10.0 g%,
infant 14.2 g% AA). The uniformly high infant RBC-AA at
delivery occurred despite between-tribe differences in
maternal RBC-AA and DHA (Fig. 1a, b), and in the
absence of a relationship between maternal and infant
RBC-AA (Fig. 2a).
Although we observed no consistent changes in maternal
RBC-AA during pregnancy, maternal RBC-AA was con-
sistently higher after 3 months of exclusive lactation as
compared to delivery, which coincided with a drop of infant
RBC-AA. The decreasing maternal AA status during preg-
nancy found by Al et al. [14] and the well-known postnatal
drop of infant RBC-AA [34] suggests that the fetus accretes
AA at the expense of maternal AA status. However, no clear
relationship between maternal and infant RBC-AA could be
demonstrated in our data, which may question the causality
of these opposing changes. The increasing maternal AA
status after delivery may derive from the discontinued uti-
lization of AA by the placenta or discontinued AA transport
to the fetus [35, 36]. Secondly, the postpartum increasing
maternal AA status may result from decreasing maternal
adipose tissue lipolysis and decreasing de novo lipogenesis
(DNL), secondary to the changing hormonal milieu after
delivery, notably the restoration of the state of diminished
insulin sensitivity/compensatory hyperinsulinemia in the
end of pregnancy. Discontinuation of the influx of these
sources of saturated fatty acids (SAFA), monosaturated fatty
acids (MUFA), and PUFA (i.e., notably linoleic acid) leads
to less dilution of LCP [35, 36]. The decrease in infant RBC-
AA may have been caused by postpartum changing infant
RBC-PL species [37] and the interrupted transplacental AA
transport [35, 36]. It can additionally be explained by a
lower conversion of LA to AA, since the infant’s capacity to
synthesize LC-PUFA decreases drastically after delivery
[38]. This lower conversion might result from lower activ-
ities of the delta-5 and delta-6 desaturase enzymes, sec-
ondary to the changing hormonal milieu after delivery.
Finally, LA intakes correlate inversely with RBC-AA [39].
Consequently, the high LA content of human milk (Kuipers,
unpublished) and the ensuing postnatal surge in the infant
LA status [35] suggest that the infant’s RBC-AA decrease
may also be a result of the high LA intake from breast milk.
At 3 months of age, infant RBC-AA in Pare (intermediate
fish) and Sengerema (high fish) was comparable to that of
their mothers, indicating a rapid postnatal adaptation of
RBC-AA to adult levels. Taken together, AA biomagnifi-
cation seems to aim at a uniform, high infant AA status
during pregnancy, most likely to sustain neurodevelopment
and infant growth [40].
Docosahexaenoic acid (DHA)
As expected [41], maternal DHA status, and thereby infant
RBC-DHA status, appeared highly sensitive to maternal
fish intake. The virtually constant maternal RBC-DHA
levels during pregnancy are in accordance with earlier data
for plasma PL [14, 42].
At delivery, infant RBC-DHA appeared higher than
maternal RBC-DHA, but this ‘‘‘biomagnification’’ occur-
red only up to about 5.6 g% maternal RBC-DHA. Beyond
this point of maternal–fetal equilibrium, infant RBC-DHA
was mostly lower than maternal RBC-DHA, suggesting
‘‘bioattenuation’’, rather than biomagnification (Fig. 2b).
The mean RBC-DHA data for a Dutch population [32]
(with low fish intakes) and a Dominican population [33]
(Caribbean Sea; with local high fish intakes) are consistent
with the switch from biomagnification to bioattenuation at
a higher maternal RBC-DHA status (Dominica: mean
maternal RBC-DHA 7.6 g%, infants 6.5 g%; Netherlands:
mean maternal 3.9 g%, infants 4.7 g%). In other words,
biomagnification might be confined to populations with
low maternal DHA status, such as typically encountered in
most Western countries, but also the currently studied Pare
(intermediate fish) and Maasai (no fish), who, in contrast to
the high fish consuming Sengerema women, exhibited
tendencies of increasing RBC-DHA during pregnancy
(Fig. 1b). Increasing amounts of DHA in the maternal
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circulation during pregnancy [43, 44] might derive from an
insulin-induced augmented elongation/desaturation of
ALA in the maternal liver, secondary to the state of
reduced insulin sensitivity/compensatory hyperinsulinism
that is characteristic for the third trimester [35]. This
maternal DHA increase is unlikely to occur at high fish
intakes such as in the women from Sengerema, because of
the negative feedback of dietary DHA on delta-5 and delta-
6 desaturase activity (Fig. 1b). The DHA increase in the
maternal circulation might be a driving force in biomag-
nification that is further supported by selective transport to
the fetal circulation [45]. Fetal albumin has been regarded
as a major contributor to LCP biomagnification because of
its ability to bind placentally transferred free LC-PUFA,
while fetal albumin concentrations at term are also 10–20%
higher, and albumin’s free fatty acid saturation is four
times lower, in the fetal circulation compared to the
maternal circulation. A role of the uniquely present alpha
fetoprotein (AFP) with similar free fatty acid loading
capacity in the fetal circulation was dismissed because of
its 1,000 times lower concentration compared to albumin in
the fetus [46]. AFP, however, has high preference for AA
and DHA and is preferentially to albumin taken up by
immature tissues, suggesting that, rather than concentra-
tions, notably fluxes of LC-PUFA trapping proteins might
be important for biomagnification. Another suggested
mechanism for the trapping of LC-PUFA is the incorpo-
ration of free LC-PUFA from the fetal circulation into
phospholipids in the liver or other organs [46].
Higher maternal compared to infant RBC-DHA contents
were previously noted after daily supplementation of
pregnant women from 20 weeks of gestation until delivery
with a high fish oil supplement containing 2.24 g DHA and
1.12 g EPA [47]. In this study, a maternal–fetal equilib-
rium was found at an RBC-DHA of 8.87 g%, named
‘‘saturation point’’. A possible explanation for the equi-
librium at higher maternal RBC-DHA than the current
about 6 g% is that fish oil was supplemented during the 3rd
trimester of pregnancy, which is characterized by reduced
insulin sensitivity and continuous adipose tissue mobili-
zation [48]. Therefore, the supplemental DHA might have
been abundantly available for incorporation into circulating
lipids, and to a lesser extent to adipose tissue stores, which
might have resulted in an overestimation of the genuine
whole body DHA status during this non-steady state con-
dition characterized by preferential nutrient transfer to the
rapidly growing infant. In our study, circulating DHA
derived from lifelong stable fish intakes that probably
caused a steady state DHA supply of the infant from both
the diet and adipose tissue stores.
Data from our populations with stable high intakes of fish
suggest that DHA bioattenuation aims at the inhibition of
abundant transplacental passage, possibly to prevent
undesired competition of DHA with AA in competition-
sensitive fetal organs. Consistent with this notion, we have
shown that at high DHA status, DHA seems to lower AA, at
least in postnatal RBC, but that in umbilical vessels, DHA
does not seem to exceed certain levels, possibly to avoid
competition with AA [49]. Prevention of DHA competition
with AA in the fetal period seems important, since fetal AA is
implicated in development and growth [10, 50].
The consistent decrease in maternal RBC-DHA during
lactation suggests that a lactating woman loses large
quantities of DHA to her infant via the milk. This post-
partum mother-to-infant DHA ‘‘surge’’ [51] may represent
a genuine form of ‘‘postnatal DHA biomagnification’’,
since it clearly occurs at the expense of the mother. This
surge coincides with a more rapid postnatal accretion of
DHA in the infant brain compared with AA [52] and may
therefore illustrate the increasing importance of DHA for
retinal and neurodevelopment [52, 53] after delivery.
The mother-to-infant DHA surge via the milk seemed
unable to prevent a RBC-DHA drop in the Maasai (low fish)
infants, prevented a decrease in the Pare (intermediate fish)
infants, but did enable a postpartum RBC-DHA increase in
the infants of the Sengerema (high fish) women (Fig. 1b). A
state of postpartum infant DHA equilibrium might therefore
be reached at lifelong DHA intakes that are somewhat
below the intakes by the Sengerema (high fish) women, who
reported to eat fish 4–5 times/week on average. Using the
joint data of all mothers and infants, we estimated that
mothers with an RBC-DHA status of about 6 g% in early
pregnancy will exhibit an RBC-DHA of about 6 g% at
delivery and will give birth to infants with about 6 g%
RBC-DHA. Whether this maternal RBC-DHA of 6 g%
constitutes an appropriate target for the DHA status of the
mother is questionable, since a maternal RBC-DHA of
6 g% is unable to prevent a drop in maternal RBC-DHA
during lactation. We [51] recently showed that maternal
postpartum DHA equilibrium is reached at a maternal RBC-
DHA content of 8 g% DHA, which is even higher than the
mean DHA status of the pregnant women in Sengerema and
coincides with an increase in infant RBC-DHA from 7 g%
at delivery to adult levels of 8 g% at 3 months.
We recently estimated that our hunter-gatherer ancestors
living in a water–land ecosystem had daily intakes of gram
amounts of AA, EPA, and DHA [5], which are substan-
tially higher than the current daily intakes of about 200 mg
AA and 275 mg DHA (men) from a typically Western diet
[8, 54]. There is also good evidence showing that daily
intakes above the recommended 450 mg DHA ? EPA
might be beneficial for the lowering of heart rate, blood
pressure, and triglycerides and to reach maximum anti-
thrombotic effects [55]. It has been proposed that optimal
protection from cardiovascular disease occurs from 8 g%
RBC EPA ? DHA [56, 57], while an RBC-DHA of 7 g%
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[i.e., RBC-(EPA ? DHA) C 8 g%], as found in healthy
subjects in Japan, might be an appropriate target to mini-
mize major depressive disorders and bipolar depression
[56]. The above-mentioned maternal postpartum equilib-
rium of 8 g% [51] is in line with these suggested targets for
adequate DHA status and also the observation that antag-
onism between EPA ? DHA and AA occurs at RBC-
(EPA ? DHA) contents above 8 g% [49].
Pregnant women in Western countries with low intakes
of fish have RBC-DHA contents well below 8 g%. For
example, non-supplemented Dutch pregnant women had
RBC-DHA contents of 4.41 g% at 36 weeks [19], while
after 12 weeks of exclusive lactation, their infants had an
RBC-DHA content of 4.73 g%. Supplementation of
220 mg DHA or 220 mg DHA ? 220 mg AA during
pregnancy resulted in a maternal RBC-DHA contents of
5.51 and 5.57 g% at 36 weeks gestation, respectively [19],
while their exclusively breastfed infants had RBC-DHA of
5.50 and 4.95 g%, respectively, at 12 weeks postpartum.
The mean daily intake of EPA ? DHA by Dutch women
amounted to 84 mg in 2003 [58]. In another study, daily
supplementation of 1.3 g DHA during 3 months of lacta-
tion resulted in a maternal RBC-DHA of 7.9 g% [59] that
coincided with an infant RBC-DHA content of 9.1 g%
[60]. Taken together, these data suggest that the presently
advised intake of 200–300 mg DHA daily during preg-
nancy and lactation [61] will be insufficient to reach the
maternal RBC-DHA target of 6 g% (i.e., postpartum infant
equilibrium) and will be even more insufficient to reach the
target of 8 g% RBC-DHA (i.e., postpartum maternal
equilibrium and infant increase) [51].
Limitations
It should be noted that, because of local constraints, the
data for each tribe were derived from different subgroups
that were studied at various occasions during pregnancy
and lactation. We interpreted differences between these
subgroups in terms of longitudinal changes, as based on
between-group statistical differences. This reasoning seems
justified because of their stable dietary intakes. In addition,
the courses of RBC-AA and DHA during pregnancy and
lactation were comparable with those of Dutch women, as
determined in plasma PL [14]. Another limitation might be
the use of RBC-LCP data as proxies for whole body LCP
status. Their use is supported by animal experiments [62],
and therefore, RBC-AA and DHA contents are nowadays
widely regarded as reliable parameters for LCP status [27].
There are, however, few data at very high DHA intakes on
the efficiency of DHA incorporation in the various com-
partments (e.g., brain), and it may be expected that each of
these compartments will ultimately become ‘‘saturated’’ to
reach compartment-specific DHA saturation levels, as e.g.,
suggested by the DHA contents of umbilical arteries and
veins [49]. The difficulty to include women in their first
trimester of pregnancy resulted into a small sample size.
Few women attend to local hospitals in early pregnancy.
Because of the low numbers, we refrained from statistical
analyses of these data. Also, the DHA status during preg-
nancy was previously shown to be influenced by the
number of previous pregnancies [63]. However, in the
present study, we found no significant DHA status differ-
ences in women with 1, 2, or multiple previous pregnancies
(data not shown). Finally, the LC-PUFA status of the
various tribes might be influenced by genetic variants (e.g.,
FADS 1 and FADS2 polymorphism), but these were not
taken into account in the present study.
Conclusions
From the present data from populations with lifelong stable
dietary habits, we conclude that infant AA status at
delivery is uniform, high, and unrelated to maternal AA
status, which might indicate the importance of fetal AA for
growth and brain development. DHA status of mother and
infant is on the other hand intimately related and strongly
dependent on the DHA intake from fish. Beyond a maternal
steady state RBC-DHA of about 6 g%, biomagnification
turns into bioattenuation, which may aim at the prevention
of DHA competition with AA in infant organs that are
sensitive to DHA versus AA competition. A maternal
RBC-DHA of about 6 g% from early pregnancy up to
delivery predicts an infant RBC-DHA of about 6 g% at
delivery, which will not change during subsequent exclu-
sive breastfeeding. Infant equilibrium, however, coincides
with maternal DHA losses during lactation. The mother-to-
infant DHA surge during lactation may represent the gen-
uine form of biomagnification. Bioattenuation, rather than
biomagnification, might be the physiological standard for
humans, because of our ancestry from the land–water
ecosystem and since studies on the prevention of cardio-
vascular disease and depression indicate optimal RBC-
DHA contents above 7 g%. It is important to stress that all
of the present data derive from populations with stable
dietary habits and may not be applicable to the state of non-
equilibrium that is typical for the so far conducted short-
term supplementation studies with DHA and AA during
pregnancy and lactation.
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